These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227 [No Abstract] [Full Text] [Related]
14. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD; O'Rourke E Transplant Proc; 1994 Oct; 26(5 Suppl 1):23-7. PubMed ID: 7940972 [No Abstract] [Full Text] [Related]
15. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient. Uber L; Cofer J; Baliga P; Rajagopalan PR Transplant Proc; 1995 Oct; 27(5 Suppl 1):42-3. PubMed ID: 7482818 [No Abstract] [Full Text] [Related]
16. CMV in kidney transplantation: a single center experience over 22 years. Nashan B; Lück R; Kliem V; Brunkhorst R; Schlitt HJ; Klempnauer J Clin Transpl; 1999; ():181-8. PubMed ID: 11038636 [TBL] [Abstract][Full Text] [Related]
17. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir. Prian GW; Koep LJ Transplant Proc; 1994 Oct; 26(5 Suppl 1):54-5. PubMed ID: 7940977 [No Abstract] [Full Text] [Related]
18. Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients. Saliba F; Eyraud D; Samuel D; David MF; Arulnaden JL; Dussaix E; Mathieu D; Bismuth H Transplant Proc; 1993 Feb; 25(1 Pt 2):1444-5. PubMed ID: 8382876 [No Abstract] [Full Text] [Related]
19. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation. van Son WJ; van den Berg AP; The TH; Tegzess AM Transplant Proc; 1993 Feb; 25(1 Pt 2):1436-8. PubMed ID: 8382873 [No Abstract] [Full Text] [Related]
20. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related] [Next] [New Search]